公司資料
Guardant Health 股價、新聞與催化劑
- 股票代碼:
- GH
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
161.67 USD (+2.84%)
收盤價
最後更新: 2026年8月17日
17.3B USD
市值
股價為何變動
As of Aug 17, 2026, GH closed up 2.84% at $161.67. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Guardant Health is a liquid-biopsy company focused on oncology diagnostics for screening, therapy selection, and disease monitoring.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Guardant sits in precision diagnostics.
商業模式特徵
The business depends on test adoption, reimbursement, clinical utility, and the expansion of liquid biopsy into more use cases.
生技產業定位
Guardant is a leading oncology-diagnostics platform whose stock moves on adoption, reimbursement, and product performance.
未來催化劑
- Guardant Health's catalysts are Shield screening adoption, Reveal MRD traction, and any reimbursement or launch step that widens the oncology-diagnostics franchise. The company improves when screening and monitoring become more routine in clinical workflows.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。